Skip to content

Clinical trials

Alzheimer Disease trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Serbia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20101
20111
20131
20143
20151
20161
20172
20211
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axovant Sciences Ltd.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Pfizer2
ACADIA Pharmaceuticals Inc.1
Avraham Pharmaceuticals Ltd1
Eli Lilly and Company1
FORUM Pharmaceuticals Inc1
H. Lundbeck A/S1
Hoffmann-La Roche1
Intra-Cellular Therapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease17
Dementia6
Mental Disorders4
Nervous System Diseases4
Psychotic Disorders4
Central Nervous System Diseases3
Cognitive Dysfunction3
Brain Diseases2
Hallucinations2
Neurocognitive Disorders2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.